Table 1.
Characteristics | Total | Survival status | P value | |
---|---|---|---|---|
Died, n = 46 | Alive, n = 29 | |||
Gender | 0.482 | |||
Female | 37 | 21 | 16 | |
Male | 38 | 25 | 13 | |
Age (years) | 0.482 | |||
<60 | 37 | 21 | 16 | |
≥60 | 38 | 25 | 13 | |
Tumor size (cm) | 1.000 | |||
≤3 | 23 | 14 | 9 | |
>3 | 52 | 32 | 20 | |
Lymph node metastasis | <0.001∗ | |||
Absent | 37 | 15 | 22 | |
Present | 38 | 31 | 7 | |
Distant metastases | 0.078 | |||
Absent | 65 | 37 | 28 | |
Present | 10 | 9 | 1 | |
TNM stage | 0.004∗ | |||
I-II | 38 | 17 | 21 | |
III-IV | 37 | 29 | 8 | |
AHNAK2 expression | 0.017∗ | |||
Low | 35 | 16 | 19 | |
High | 40 | 30 | 10 |
Statistical analyses were performed by the Pearson χ2 test. ∗P < 0.05 was considered to be statistically significant.